News

There are tried and true methods to manage through turbulent times, both at the business and personal level. We can apply these methods as healthcare leaders.

FDA granted a new indication to a device that can help reduce the symptoms of withdrawal from the prescription pain drugs.

Because of the impact of Hurricanes Maria and Irma on Puerto Rico’s infrastructure and drug manufacturing, hospitals face an ongoing shortage of IV fluids manufactured there.

A report on a pair of surveys from West reveals interesting findings about patient engagement, prevention, wellness, and quality of care.

: In some cases of healthcare fraud, it’s easy to spot red flags. But in large healthcare organizations, or on the payer end, fraud and waste can be more difficult to detect through layers and layers of data.

New healthcare fraud schemes are emerging. Here are a few of the most noteworthy.

Researchers share surprising findings about PCT-guided therapy in antibiotic management in patients with respiratory infections.

While these types of programs have been in place for several years, it can be difficult to gauge who is using them and how, and whether they are achieving their intended goal.

Fluctuations in drug pricing and medication shortages are among the reasons for rising drug prices. Learn how you can protect your hospital’s bottom line.

CVS Health’s Troyen A. Brennan, MD, MPH, brings attention to a unique specialty pharmacy model and value-based contracting.

FDA approved the first drug in the United States that has a digital ingestion tracking system, which records when the medication was taken.

If your organization is managing a risk-based contract, you are likely working hard to engage physicians. But are you modifying those efforts based on whether physicians are independent or employed? Here’s why you should.

FDA warned 4 companies, which are claiming that their products containing cannabidiol, can treat or cure cancer.

The first 2-dose hepatitis B vaccine, which was recently approved by FDA, is expected to be commercially available in early 2018.

FDA warns that this compounded eye drug could lead to a disease that causes blindness.

More education is needed for diabetic patients after a patient died from incorrectly using an insulin pen, according to a new warning from the Institute for Safe Medication Practices.

If it is approved by FDA, an investigational drug to improve glycemic control in patients with type 2 diabetes will likely be a strong competitor to Eli Lilly’s dulaglutide (Trulicity).

FDA approved the herpes zoster vaccine (Shingrix, GlaxoSmithKline) to treat shingles in adults aged 50 years and older.

Soon after President Donald Trump declared the opioid abuse crisis a “public health emergency," shareholder activist groups said they aim to hold drug manufacturers and distributors liable for their part in the crisis.

Experts say a cancer care revolution is here. Here’s a closer look at some advancements in cancer treatments to watch.

A new survey on genetic testing has surprisingly results on consumer acceptance and impact for healthcare executives.

A survey unveiled at the HealthCare Executive Group’s Annual Forum divulges surprising findings about healthcare technology and innovation.

We asked successful healthcare industry leaders to share their top tips for young executives. Here’s what they said.

A new survey from consumer health companies has revealing findings about American health and well-being.

Genetics and genomics are starting to have an impact on cardiovascular care. Here’s what payers should consider when deciding whether to cover a gene expression test.

A Kaiser Permanente study found that a new way to test for HPV has the potential to increase efficiency and decrease waste.

Here are four ways CMS’ final rule related to the 340B Drug Pricing Program could affect the healthcare industry.